Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-16

FDA Approved: NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved a supplemental application for a norethindrone acetate and ethinyl estradiol oral contraceptive product from Glenmark.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Norethindrone acetate and ethinyl estradiol (Norethindrone acetate and ethinyl estradiol)

Snippet

SUPPL AP for NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)